For Southeastern United States FamiliesAlzheimer's Second Opinion from Cuba in Southeastern United States
The Southeastern United States — including Florida, Mississippi, Louisiana, South Carolina, and neighboring states — is home to over 1.1 million Americans living with Alzheimer's. This region has some of the highest Alzheimer's prevalence rates in the nation, driven by large senior populations, significant African American communities (who face disproportionately high dementia risk), and high diabetes rates that compound cognitive decline. Miami, Tampa, and Fort Lauderdale offer the most convenient direct charter flights to Havana, while Atlanta, Charlotte, and New Orleans provide connecting flight options.
1.1M
Southeastern United States residents with Alzheimer's
6
states in region
1–5 hours (varies by departure city)
to Havana
Direct
flights available
Why Seek a Second Opinion from Cuba Across Southeastern United States
A second opinion can be invaluable when navigating Alzheimer's disease — particularly when U.S. treatment options are limited, when the diagnosis is uncertain, or when the family wants to explore alternative approaches.
American families seek second opinions from Cuba's neurology team for several reasons: FDA-approved treatments (lecanemab, donanemab) are limited to mild Alzheimer's — for patients whose disease has progressed beyond the mild stage, U.S. options are primarily symptom management. Cuba offers NeuroEPO research and intensive rehabilitation for mild-to-moderate Alzheimer's. Additionally, CIREN's 4–6 hours of daily multidisciplinary therapy is not available in the U.S. healthcare system.
The second opinion process is simple: submit neuropsychological testing, MRI, blood work, and medication list for review. Cuba's neurology team provides a fresh, independent evaluation of the patient's cognitive stage, imaging, and treatment history — offering a different perspective from the U.S. neurologist. The Cuban medical report is shared with the patient's U.S. physician for coordinated care. Cuba's program is complementary, not substitutive — patients continue their U.S. medications and follow-up.
No treatment currently cures Alzheimer's disease. Cuba's program aims to slow cognitive decline, maintain function, and improve quality of life. NeuroEPO is investigational and not FDA-approved. Treatment suitability is determined after individual medical evaluation. Individual outcomes vary.
State-by-State Guides
Alzheimer's Second Opinion from Cuba by State in Southeastern United States
Select your state for detailed information about alzheimer's second opinion from cuba options, travel logistics, and state-specific resources.
City-Level Guides
Alzheimer's Second Opinion from Cuba by City in Southeastern United States
Travel from Southeastern United States
Getting to Havana from Southeastern United States
Major Departure Airports
- Miami (MIA)
- Tampa (TPA)
- Fort Lauderdale (FLL)
- Atlanta (ATL)
- Charlotte (CLT)
- New Orleans (MSY)
Travel time: 1–5 hours (varies by departure city)
Travel Authorization
- • U.S. citizens can travel to Cuba under approved categories
- • SMC Salud provides letter of medical necessity
- • Treatment confirmation documentation included
- • Airport reception and ground transport in Havana
- • English-speaking coordinators throughout your stay
Frequently Asked Questions
Questions from Southeastern United States Families
Yes. U.S. citizens can travel to Cuba under approved categories. SMC Salud provides all necessary documentation, including the letter of medical necessity and treatment confirmation, to support travel authorization. Our team guides you through the entire process to ensure compliance with all regulations.
Ready to Explore Alzheimer's Second Opinion from Cuba in Cuba?
Submit your medical records for a complimentary review. Families across Southeastern United States receive a personalized treatment proposal within 5–10 business days.